EGFR and neoplasm: Determining how to predict whether a patient will have skin toxicity is an important area of investigation In 2004, Amador et al. (125) found that the number of single sequence repeats in EGFR intron 1 was related to the skin toxicity and anti-tumor activity of EGFR inhibitors.